Back to KYMR
Candriam S.C.A. KYMR Position History
Kymera Therapeutics, Inc. • Healthcare
Quarters held
6
Latest value
$21.3M
Q3 2026
Peak value
$22.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $10.8M |
| Q4 2025 | $15.7M |
| Q4 2025 | $15.7M |
| Q1 2026 | $16.8M |
| Q2 2026 | $22.1M |
| Q3 2026 | $21.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $21.3M | 189.7K | — | — |
| Q2 2026 | $22.1M | 192.9K | — | — |
| Q1 2026 | $16.8M | 201.7K | — | — |
| Q4 2025 | $15.7M | 201.7K | — | — |
| Q4 2025 | $15.7M | 201.7K | — | — |
| Q3 2025 | $10.8M | 191.6K | — | — |